Tower Research Capital (TRC)’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $127K | Buy |
|
|||||
|
2025
Q4 | $15.2K | Sell |
|
|||||
|
2025
Q3 | $92.7K | Buy |
|
|||||
|
2025
Q2 | $34.1K | Buy |
|
|||||
|
2025
Q1 | $15.2K | Sell |
|
|||||
|
2024
Q4 | $135K | Buy |
|
|||||
|
2024
Q3 | $14.7K | Sell |
|
|||||
|
2024
Q2 | $326K | Buy |
|
|||||
|
2024
Q1 | $28.1K | Sell |
|
|||||
|
2023
Q4 | $27.8K | Buy |
|
|||||
|
2023
Q3 | $20.8K | Sell |
|
|||||
|
2023
Q2 | $37.9K | Sell |
|
|||||
|
2023
Q1 | $91K | Buy |
|
|||||
|
2022
Q4 | $53K | Buy |
|
|||||
|
2022
Q3 | $44K | Sell |
|
|||||
|
2022
Q2 | $67K | Buy |
|
|||||
|
2022
Q1 | $18K | Buy |
|
|||||
|
2021
Q4 | $17K | Buy |
|
|||||
|
2021
Q3 | $12K | Buy |
|
|||||
|
2021
Q2 | $0 | Buy |
|